Molecular genetics in acute leukemia

Leukemia

Volumn 14, Issue 3, 2000, Pages 513-517

  Rowley, J D ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Acute leukemia; Chromosome translocations in leukemia; Fusion genes; Genotype specific therapy; MLL

Indexed keywords

ACUTE LEUKEMIA; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CONFERENCE PAPER; CYTOGENETICS; MOLECULAR GENETICS; PRIORITY JOURNAL;

EID: 0034008506     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401600     Document Type: Conference Paper

References (18)

1. Veldman T, Vignon C, Schrock E, Rowley JD, Ried T. Hidden chromosome abnormalities in haematological malignancies detected by multicenter spectral karyotyping. Nat Genet 1997; 15: 406-410.
2. Rowley JD, Reshmi S, Carlson K, Roulston D. Spectral karyotype analysis of T-cell acute leukemia. Blood 1999; 93: 2038-2042.
3. Fleischman EW, Reshmi S, Sokova OI et al. Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies. Cancer Genet Cytogenet 1999; 108: 166-170.
4. Carter NP, Ferguson-Smith ME, Affara NA, Briggs H, Ferguson-Smith MA. Study of X chromosome abnormality in XX males using bivariate flow karyotype analysis and flow sorted dot blots. Cytometry 1990; 11: 202-207.
5. Rowley JD, Golomb HM, Vardiman J, Fukuhara S, Dougherty C, Potter D. Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia, Int J Cancer 1977; 20: 869-872.
6. Grimwade D, Walker H, Oliver F et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322-2333.
7. Rowley JD. The critical role of chromosome translocations in human leukemias. Annu Rev Genet 1998; 32: 495-519.
8. Sakurai M, Swansbury GJ. Fourth International Workshop on Chromosomes in Leukemia 1982: overview of association between chromosome pattern and cell morphology, age, sex, and race. Cancer Genet Cytogenet 1984; 11: 265-274.
9. Rabbitts TH. Chromosomal translocations in human cancer. Nature 1994; 372: 143-149.
10. Look TA. Oncogenic transcription factors in human acute leukemia. Science 1997; 278: 1059-1064.
11. Grimwade D. Howe K, Langabeer S et al. Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the MRC ATRA trial. MRC Adult Leukaemia Working Party. Br J Haematol 1996; 94: 557-573.
12. Sato Y, Bohlander SK, Kobayashi H et al. Heterogeneity in the breakpoints in balanced rearrangements involving bank 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL (ETV6) is involved in only one half. Blood 1997; 90: 4886-4893.
13. Rowley JD, Reshmi S, Sobulo O et al. All patients with the t(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood 1997; 90: 535-541.
14. Thirman MJ, Gill HJ, Burnett RC et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. New Engl J Med 1993; 329: 909-914.
15. Nucifora G, Dickstein JI, Torbenson V, Roulston D, Rowley JD, Vardiman JW. Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). Leukemia 1994; 8: 1533-1538.
16. Warrell RP Jr, He LZ, Richon V, Calleja E, Pandolfi PP. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst 1998; 90: 1621-1625.
17. He LZ, Guidez F, Tribioli C et al. Distinct interactions of PML-RARalpha and PLZF-RARalpha with corepressors determine differential responses to RA in APL. Nat Genet 1998; 18: 126-135.
18. Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci USA 1998; 95: 10860-10865.